Logo image of GLRE

GREENLIGHT CAPITAL RE LTD-A (GLRE) Stock Fundamental Analysis

NASDAQ:GLRE - Nasdaq - KYG4095J1094 - Common Stock - Currency: USD

14.91  +0.18 (+1.22%)

After market: 14.91 0 (0%)

Fundamental Rating

4

Overall GLRE gets a fundamental rating of 4 out of 10. We evaluated GLRE against 144 industry peers in the Insurance industry. GLRE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GLRE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

GLRE had positive earnings in the past year.
In the past year GLRE had a positive cash flow from operations.
Each year in the past 5 years GLRE has been profitable.
The reported operating cash flow has been mixed in the past 5 years: GLRE reported negative operating cash flow in multiple years.
GLRE Yearly Net Income VS EBIT VS OCF VS FCFGLRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

GLRE has a Return On Assets of 2.14%. This is comparable to the rest of the industry: GLRE outperforms 53.47% of its industry peers.
The Return On Equity of GLRE (6.89%) is worse than 70.83% of its industry peers.
Industry RankSector Rank
ROA 2.14%
ROE 6.89%
ROIC N/A
ROA(3y)2.92%
ROA(5y)2.05%
ROE(3y)8.8%
ROE(5y)6.19%
ROIC(3y)N/A
ROIC(5y)N/A
GLRE Yearly ROA, ROE, ROICGLRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

GLRE has a Profit Margin of 6.85%. This is comparable to the rest of the industry: GLRE outperforms 46.53% of its industry peers.
In the last couple of years the Profit Margin of GLRE has grown nicely.
The Operating Margin of GLRE (1.29%) is worse than 81.94% of its industry peers.
In the last couple of years the Operating Margin of GLRE has declined.
Industry RankSector Rank
OM 1.29%
PM (TTM) 6.85%
GM N/A
OM growth 3Y-37.65%
OM growth 5YN/A
PM growth 3Y30.1%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLRE Yearly Profit, Operating, Gross MarginsGLRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
GLRE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, GLRE has less shares outstanding
GLRE has a better debt/assets ratio than last year.
GLRE Yearly Shares OutstandingGLRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GLRE Yearly Total Debt VS Total AssetsGLRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

GLRE has a debt to FCF ratio of 0.58. This is a very positive value and a sign of high solvency as it would only need 0.58 years to pay back of all of its debts.
GLRE has a Debt to FCF ratio of 0.58. This is in the better half of the industry: GLRE outperforms 77.78% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that GLRE is not too dependend on debt financing.
GLRE has a Debt to Equity ratio of 0.09. This is in the better half of the industry: GLRE outperforms 79.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.58
Altman-Z N/A
ROIC/WACCN/A
WACC9.61%
GLRE Yearly LT Debt VS Equity VS FCFGLRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GLRE Yearly Current Assets VS Current LiabilitesGLRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

GLRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.86%.
The Earnings Per Share has been growing by 34.26% on average over the past years. This is a very strong growth
Looking at the last year, GLRE shows a small growth in Revenue. The Revenue has grown by 2.65% in the last year.
The Revenue has been growing slightly by 4.45% on average over the past years.
EPS 1Y (TTM)-56.86%
EPS 3Y34.26%
EPS 5YN/A
EPS Q2Q%10.26%
Revenue 1Y (TTM)2.65%
Revenue growth 3Y3.53%
Revenue growth 5Y4.45%
Sales Q2Q%-3.36%

3.2 Future

GLRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.14% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y34.88%
EPS Next 2Y16.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLRE Yearly Revenue VS EstimatesGLRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
GLRE Yearly EPS VS EstimatesGLRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6 -8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.56, which indicates a very decent valuation of GLRE.
Based on the Price/Earnings ratio, GLRE is valued a bit cheaper than the industry average as 60.42% of the companies are valued more expensively.
GLRE is valuated cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
GLRE is valuated reasonably with a Price/Forward Earnings ratio of 9.14.
62.50% of the companies in the same industry are more expensive than GLRE, based on the Price/Forward Earnings ratio.
GLRE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.46.
Industry RankSector Rank
PE 11.56
Fwd PE 9.14
GLRE Price Earnings VS Forward Price EarningsGLRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

70.14% of the companies in the same industry are more expensive than GLRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.01
EV/EBITDA N/A
GLRE Per share dataGLRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

GLRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GLRE's earnings are expected to grow with 16.14% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y16.14%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GLRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (6/24/2025, 8:00:00 PM)

After market: 14.91 0 (0%)

14.91

+0.18 (+1.22%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04
Inst Owners49.72%
Inst Owner Change3.99%
Ins Owners24.36%
Ins Owner Change-0.23%
Market Cap515.29M
Analysts43.33
Price TargetN/A
Short Float %0.81%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1900.98%
Min EPS beat(2)-3870.59%
Max EPS beat(2)68.63%
EPS beat(4)2
Avg EPS beat(4)-939.86%
Min EPS beat(4)-3870.59%
Max EPS beat(4)68.63%
EPS beat(8)5
Avg EPS beat(8)-435.43%
EPS beat(12)7
Avg EPS beat(12)-367.94%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.56
Fwd PE 9.14
P/S 0.77
P/FCF 5.01
P/OCF 4.95
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)1.29
EY8.65%
EPS(NY)1.63
Fwd EY10.95%
FCF(TTM)2.98
FCFY19.98%
OCF(TTM)3.01
OCFY20.18%
SpS19.42
BVpS19.3
TBVpS19.3
PEG (NY)0.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.14%
ROE 6.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.29%
PM (TTM) 6.85%
GM N/A
FCFM 15.34%
ROA(3y)2.92%
ROA(5y)2.05%
ROE(3y)8.8%
ROE(5y)6.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-37.65%
OM growth 5YN/A
PM growth 3Y30.1%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.58
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.79
Cash Conversion N/A
Profit Quality 223.86%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC9.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.86%
EPS 3Y34.26%
EPS 5YN/A
EPS Q2Q%10.26%
EPS Next Y34.88%
EPS Next 2Y16.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.65%
Revenue growth 3Y3.53%
Revenue growth 5Y4.45%
Sales Q2Q%-3.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-88.61%
EBIT growth 3Y-35.45%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y580.08%
FCF growth 3YN/A
FCF growth 5Y132.58%
OCF growth 1Y585.08%
OCF growth 3YN/A
OCF growth 5Y133.03%